Advanced search
Publication Cover
OncoImmunology Volume 4, 2015 - Issue 3
Submit an article Journal homepage
2,486
Views
41
CrossRef citations to date
0
Altmetric
Author's View

Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy

Ilkka LiikanenTransplantation laboratory; Cancer Gene Therapy Group (CGTG); Haartman Institute; University of Helsinki; Helsinki, Finland
,
Anniina KoskiTransplantation laboratory; Cancer Gene Therapy Group (CGTG); Haartman Institute; University of Helsinki; Helsinki, Finland
,
Maiju Merisalo-SoikkeliTransplantation laboratory; Cancer Gene Therapy Group (CGTG); Haartman Institute; University of Helsinki; Helsinki, Finland
,
Otto HemminkiTransplantation laboratory; Cancer Gene Therapy Group (CGTG); Haartman Institute; University of Helsinki; Helsinki, Finland
,
Minna OksanenTransplantation laboratory; Cancer Gene Therapy Group (CGTG); Haartman Institute; University of Helsinki; Helsinki, Finland
,
Kalevi KairemoDocrates Cancer Center; Helsinki, Finland
,
Timo JoensuuDocrates Cancer Center; Helsinki, Finland
,
Anna KanervaTransplantation laboratory; Cancer Gene Therapy Group (CGTG); Haartman Institute; University of Helsinki; Helsinki, Finland;Department of Obstetrics and Gynecology; HUCH, Helsinki, Finland
&
Akseli HemminkiTransplantation laboratory; Cancer Gene Therapy Group (CGTG); Haartman Institute; University of Helsinki; Helsinki, Finland;TILT Biotherapeutics Ltd.; Helsinki, FinlandCorrespondence[email protected]
 show all
Article: e989771 | Received 05 Sep 2014, Accepted 15 Nov 2014, Published online: 02 Apr 2015

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.